CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
Explore some of the common pitfalls witnessed in healthcare environments, as well as guidance for implementing a penetration testing program.
ECOA RESOURCES
-
See how the clinical trial landscape has changed, and why many sponsors are choosing to make digital and decentralized trials a key part of their future.
-
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
-
Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
ECONSENT RESOURCES
-
See how the clinical trial landscape has changed, and why many sponsors are choosing to make digital and decentralized trials a key part of their future.
-
Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
EPRO RESOURCES
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.
-
Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.